Skip to main content

Table 3 Stratified analysis on the effects of NAFLD on the platelet count reduction in different subgroups

From: Risk of reduced platelet counts in patients with nonalcoholic fatty liver disease (NAFLD): a prospective cohort study

Variables

  

Unadjusted

Adjusted*

With outcome

N (%)

Without outcome

N (%)

OR (95% CI)

P value

OR (95% CI)

P value

Gender

 Male

Non-NAFLD

25(5.08%)

467(94.42%)

Ref(1)

 

Ref(1)

 

NAFLD

33(7.27%)

421(92.73%)

1.46(0.86,2.50)

0.1633

1.68(0.85,3.32)

0.1359

 Female

Non-NAFLD

8(2.82%)

276(97.18%)

Ref(1)

 

Ref(1)

 

NAFLD

4(5.48%)

69(94.52)

2.00(0.59,6.84)

0.2689

3.47(0.53,22.97)

0.1943

Age (years)

 ≤51

Non-NAFLD

16(3.52%)

438(96.48%)

Ref(1)

 

Ref(1)

 

NAFLD

9(4.21%)

205(95.79%)

1.20(0.52,2.77)

0.6654

1.46(0.47,4.54)

0.5188

 > 51

Non-NAFLD

17(5.28%)

305(94.72%)

Ref(1)

 

Ref(1)

 

NAFLD

28(8.95%)

285(91.05%)

1.67(0.98,2.85)

0.0750

2.01(0.91,4.44)

0.0846

BMI (kg/m2)

 ≤23

Non-NAFLD

19(4.14%)

440(95.86%)

Ref(1)

 

Ref(1)

 

NAFLD

8(15.09%)

45(84.91%)

4.12(1.71,9.94)

0.0016

3.36(1.20,9.45)

0.0216

 > 23

Non-NAFLD

14(4.42%)

303(95.58%)

Ref(1)

 

Ref(1)

 

NAFLD

29(6.12%)

445(93.88%)

1.41(0.73,2.71)

0.3032

1.01(0.49,2.11)

0.9779

UA (umol/L)

 ≤344.3

Non-NAFLD

17(3.53%)

464(96.47%)

Ref(1)

 

Ref(1)

 

NAFLD

14(8.19%)

157(91.81%)

2.43(1.17,5.05)

0.0169

3.69(1.35, 10.10)

0.0100

 > 344.3

Non-NAFLD

16(5.42%)

279(94.58%)

Ref(1)

 

Ref(1)

 

NAFLD

23(6.46%)

333(93.54%)

1.20(0.62, 2.33)

0.5794

0.99(0.45, 2.21)

0.9844

  1. BMI: body mass index; UA: uric-acid;
  2. Values are OR (95% CI), participants n = 1303. Analysis according to gender distribution, median values of age, body mass index (BMI) and uric-acid (UA). When compared in different age groups, the OR was adjusted for gender, BMI, blood pressure and etc. When compared in different gender groups, the OR was adjusted for age, BMI, blood pressure and etc. When compared in different BMI groups, the OR was adjusted for age, gender, blood pressure and etc. When compared in different Uric acid groups, the OR was adjusted for age, gender, BMI, blood pressure and etc. P-values less than 0.05 were considered statistically significant